(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.

The FDA is attempting to rehire some of the 300 employees it recently dismissed, including scientists responsible for ...

Boston Scientific (NYSE: BSX) announced that its Europe-based subsidiary priced a public offering totaling $1.57 billion ...

Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest Diagnostics.

OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities.

Philips (NYSE: PHG) issued an urgent field safety notice to warn of a potential safety issue with its IntelliSpace Cardiovascular system.

Neurovalens said its Modius Sleep insomnia treatment will be available to veterans through a U.S. Department of Veterans Affairs program.

The Portage, Michigan–based orthopedic and surgical device giant announced last month that it struck a deal to acquire Inari ...

The AP reported that the Trump administration's latest federal cuts have a significant effect on medical device regulation at ...

The FDA today issued a notice labeling the recall of Boston Scientific Accolade pacemaker devices serious as it may cause ...

Valencia Technologies announced today that it received a strategic investment totaling up to $35 million and appointed a new ...

CMR Surgical today announced that more than 30,000 surgical cases around the world have been completed using its Versius ...